Fexofenadine hydrochloride--a new anti-histaminic drug.

نویسندگان

  • B Amichai
  • M H Grunwald
  • L Brenner
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of a Combination of a Unani Pharmacopeal Preparation (itrifal Ustukhudoos) with Cloves (qaranfal) in Allergic Rhinitis – a Preliminary Clinical Study

Allergic Rhinitis is typically characterized by sneezing, rhinorrhoea, nasal obstruction, nasal, conjunctival & pharyngeal itching and lacrimation all occurring in a temporal relation to allergen exposure. The peak incidence of this disease occurs in childhood and adolescence, with most of the cases belonging to the atopic category.There is a high incidence of patients of allergic rhinitis atte...

متن کامل

A new stability - indicating RP - HPLC method for the simultaneous determination of fexofenadine hydrochloride and montelukast in combined dosage form

A new stability-indicating RP-HPLC method was developed for the simultaneous determination of fexofenadine hydrochloride and montelukast in combined dosage form, using a Aligent, Zorbax (Make: 150 mmx4.6 mm I.D; particle size 5μm and a mobile phase composed of phospahte buffer (pH 4.0): Acetonitile (60:40 v/v) at a flow rate of 1.0mL/min. The retention times of fexofenadine hydrochloride and mo...

متن کامل

A review of Fexofenadine hydrochloride

Fexofenadine is the hydrochloride salt of terfenadine’s active metabolite. In 2006, the FDA approved an oral suspension for the management of chronic idiopathic urticaria and seasonal allergic rhinitis in children. This review article summarizes the clinical pharmacology, therapeutic applications, drug-drug interactions, adverse events and food-drug interactions of fexofenadine that have been r...

متن کامل

Fexofenadine hydrochloride in the treatment of allergic disease: a review

Fexofenadine is a selective, non-sedating H1 receptor antagonist, marketed in the United States since 2000. The FDA approved an oral suspension in 2006, for the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria in children. The tablet, capsule, and oral suspension are bioequivalent. Although fexofenadine does not use P450 CYP 3A4 it does interact with a number of drugs at...

متن کامل

Stability-indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride

A simple, specific, accurate, and stability-indicating reversed-phase high-performance liquid chromatographic method was developed for the simultaneous determination of montelukast and fexofenadine hydrochloride, using a Lichrospher(®) 100, RP-18e column and a mobile phase composed of methanol:0.1% o-phosphoric acid (90:10 v/v), pH 6.8. The retention times of montelukast and fexofenadine hydroc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Israel Medical Association journal : IMAJ

دوره 3 3  شماره 

صفحات  -

تاریخ انتشار 2001